HomeIMNM • NASDAQ
add
Immunome Inc
Previous close
$21.18
Day range
$21.00 - $21.66
Year range
$5.15 - $25.30
Market cap
2.37B USD
Avg Volume
2.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.94M | 14.90% |
Net income | -57.46M | -21.99% |
Net profit margin | — | — |
Earnings per share | -0.65 | 16.67% |
EBITDA | -59.55M | -37.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 272.64M | 13.54% |
Total assets | 299.38M | 16.54% |
Total liabilities | 35.46M | -15.56% |
Total equity | 263.92M | — |
Shares outstanding | 91.71M | — |
Price to book | 7.35 | — |
Return on assets | -50.48% | — |
Return on capital | -55.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -57.46M | -21.99% |
Cash from operations | -40.51M | -18.56% |
Cash from investing | 123.88M | 414.08% |
Cash from financing | 45.39M | 14,781.64% |
Net change in cash | 128.76M | 1,418.75% |
Free cash flow | -20.54M | 21.40% |
About
Founded
2006
Headquarters
Website
Employees
168
